To Evaluate Safety and Efficacy of Pathadi Ghanavati and Pathadi Oil in Psoriasis
Phase 2
- Conditions
- Health Condition 1: L409- Psoriasis, unspecified
- Registration Number
- CTRI/2021/12/038806
- Lead Sponsor
- HON SHRI ANNASAHEB DANGE AYURVED MEDICAL COLLEGE AND POSTGRADUATE CENTER ASHTA SANGLI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients who are having sign and symptoms of Psoriasis
2.Patients suffering from psoriasis with less than 50% of the body surface involvement
Exclusion Criteria
1.Pregnant and lactating mothers
2.Patients having any severe systemic disorders like Diabetes Mellitus, Cancer etc.
3.Patients suffering from psoriasis with more than 50% of the body surface involvement and with other co morbidities
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Improvement in Dermatology Life Quality Index(DLQI) <br/ ><br>2. Improvement in Signs and Symptoms of PsoriasisTimepoint: 7th Day, 14th Day,21th Day,30th Day
- Secondary Outcome Measures
Name Time Method 1. Reduction in mean Simplified Psoriasis Area and Severity Index Score (SPASI) <br/ ><br>2. Reduction in mean Physicians Global Assessment Scale Score (PGA) <br/ ><br>3. Reduction in mean Physicians Global Assessment and Body Surface Area Scale ScoreTimepoint: 7th Dya, 14th Day, 21th Day,30th Day